Thermal sensitisation by lonidamine of human melanoma cells grown at low extracellular pH

References

• Fang J, Quinones QJ, Holman TL, Morowitz MJ, Wang Q, Zhao H, et al. The H+-linked monocarboxylate transporter (MCT1/SLC16A1): A potential therapeutic target for high-risk neuroblastoma. Mol Pharmacol 2006;70:2108–15
   PubMed Web of Science ®Google Scholar
• Floridi A, Lehninger AL. Action of the antitumor and antispermatogenic agent lonidamine on electron transport in Ehrlich ascites tumor mitochondria. Arch Biochem Biophys 1983;226:73–83
   PubMed Web of Science ®Google Scholar
• Nath K, Nelson DS, Ho AM, Lee, S-C, Darpolor MM, Pickup S, et al. 31P and 1H MRS of DB-1 melanoma xenografts: lonidamine selectively decreases tumor intracellular pH and energy status and sensitizes tumors to melphalan. NMR Biomed 2012;26:98–105
   PubMedGoogle Scholar
• Kim JH, Kim SH, Alfieri A, Young CW, Silvestrini B. Lonidamine: A hyperthermic sensitizer of HeLa cells in culture and of the Meth-A tumor in vivo. Oncology 1984;41:30–5
   PubMed Web of Science ®Google Scholar
• Stryker JA, Gerweck LE. Lonidamine-induced, pH dependent inhibition of cellular oxygen utilization. Radiat Res 1988;113:356–61
   PubMed Web of Science ®Google Scholar
• Raaphorst GP, Feeley MM, Martin L, Danjoux CE, Maroun J, Desanctis AJ, et al. Enhancement of sensitivity to hyperthermia by lonidamine in human cancer cells. Int J Hyperthermia 1991;7:763–72
   PubMed Web of Science ®Google Scholar
• Ben-Yoseph O, Lyons JC, Song CW, Ross BD. Mechanism of action of lonidamine in the 9L brain tumor model involves inhibition of lactate efflux and intracellular acidification. J Neurooncol 1998;36:149–57
   PubMedGoogle Scholar
• Silvestrini B, Hahn GM, Cioli V, De Martino C. Effects of lonidamine alone or combined with hyperthermia in some experimental cell and tumour systems. Br J Cancer 1983;47:221–31
   PubMedGoogle Scholar
• Caputo A, Silvestrini B. Lonidamine, a new approach to cancer therapy. Oncology 1984;41:2–6
   PubMed Web of Science ®Google Scholar
• Citro G, Cucco C, Verdina A, Zupi G. Reversal of adriamycin resistance by lonidamine in a human breast cancer cell line. Br J Cancer 1991;64:534–6
   PubMed Web of Science ®Google Scholar
• Teicher BA, Herman TS, Holden SA, Epelbaum R, Liu S, Frei III E. Lonidamine as a modulator of alkylating agent activity in vitro and in vivo. Cancer Res 1991;51:780–4
   PubMed Web of Science ®Google Scholar
• Di Cosimo S, Ferretti G, Papaldo P, Carlini P, Fabi A, Cognetti F. Lonidamine: Efficacy and safety in clinical trials for the treatment of solid tumors. Drugs Today (Barc) 2003;39:157–74
   PubMed Web of Science ®Google Scholar
• Gerweck LE. Modification of cell lethality at elevated temperatures. The pH effect. Radiat Res 1977;70:224–35
   PubMed Web of Science ®Google Scholar
• Freeman ML, Raaphorst GP, Hopwood LE, Dewey WC. The effect of pH on cell lethality induced by hyperthermic treatment. Cancer 1980;45:2291–300
   PubMed Web of Science ®Google Scholar
• Hofer KG, Mivechi NF. Tumor cell sensitivity to hyperthermia as a function of extracellular and intracellular pH. J Natl Cancer Inst 1980;65:621–5
   PubMed Web of Science ®Google Scholar
• Chu G, Dewey WC. The role of low intracellular or extracellular pH in sensitization to hyperthermia. Radiat Res 1988;114:154–67
   PubMed Web of Science ®Google Scholar
• Chu GL, Wang Z, Hyun WC, Pershadsingh HA, Fulwyler MJ, Dewey WC. The role of intracellular pH and its variance in low pH sensitization of killing by hyperthermia. Radiat Res 1990;122:288–93
   PubMed Web of Science ®Google Scholar
• Lyons JC, Kim GE, Song CW. Modification of intracellular pH and thermosensitivity. Radiat Res 1992;129:79–87
   PubMed Web of Science ®Google Scholar
• Coss RA, Storck CW, Wachsberger PR, Reilly J, Leeper DB, Berd D, et al. Acute extracellular acidification reduces intracellular pH, 42 °C-induction of heat shock proteins and clonal survival of human melanoma cells grown at pH 6.7. Int J Hyperthermia 2004;20:93–106
   PubMed Web of Science ®Google Scholar
• Coss, RA, Storck CW, Daskalakis C, Berd D, Wahl ML. Intracellular acidification abrogates the heat shock response and compromises survival of human melanoma cells. Mol Cancer Ther 2003;2:383–8
   PubMed Web of Science ®Google Scholar
• Atema A, Buurman KJ, Noteboom E, Smets LA. Potentiation of DNA-adduct formation and cytotoxicity of platinum-containing drugs by low pH. Int J Cancer 1993;54:166–72
   PubMed Web of Science ®Google Scholar
• Jahde E, Glusenkamp KH, Klunder I, Hulser DF, Tietze LF, Rajewsky MF. Hydrogen ion-mediated enhancement of cytotoxicity of bis-chloroethylating drugs in rat mammary carcinoma cells in vitro. Cancer Res 1989;49:2965–72
   PubMed Web of Science ®Google Scholar
• Jahde E, Glusenkamp KH, Rajewsky MF. Nigericin enhances mafosfamide cytotoxicity at low extracellular pH. Cancer Chemother Pharmacol 1991;27:440–4
   PubMedGoogle Scholar
• Jahde E, Roszinski S, Volk T, Glusenkamp KH, Wiedemann G, Rajewsky MF. Metabolic response of AH13r rat tumours to cyclophosphamide as monitored by pO2 and pH semi-microelectrodes. Eur J Cancer 1992;29:116–22
   Google Scholar
• Gerweck LE, Vijayappa S, Kozin S. Tumor pH controls the in vivo efficacy of weak acid and base chemotherapeutics. Mol Cancer Ther 2006;5:1275–9
   PubMed Web of Science ®Google Scholar
• Wahl ML, Owen JA, Burd R, Herlands RA, Nogami SS, Rodeck U, et al. Regulation of intracellular pH in human melanoma: potential therapeutic implications. Mol Cancer Ther 2002;1:617–28
   PubMed Web of Science ®Google Scholar
• Hill LL, Korngold R, Jaworsky C, Murphy G, McCue P, Berd D. Growth and metastasis of fresh human melanoma tissue in mice with severe combined immunodeficiency. Cancer Res 1991;51:4937–41
   PubMed Web of Science ®Google Scholar
• Owen CS, Wahl ML, Leeper DB, Perry HD, Bobyock SB, Russel M, et al. Accurate whole spectrum measurements of intracellular pH and [Na+]. J Fluorescence 1995;5:329–35
   PubMedGoogle Scholar
• Wahl ML, Coss RA, Bobyock SB, Leeper DB, Owen CS. Thermotolerance and intracellular pH in two Chinese hamster cell lines adapted to growth at low pH. J Cell Physiol 1996;166:438–45
   PubMed Web of Science ®Google Scholar
• Owen CS, Pooler PM, Wahl ML, Coss RA, Leeper DB. Altered proton extrusion in cells adapted to growth at low extracellular pH. J Cell Physiol 1997;167:397–405
   Google Scholar
• Wahl ML, Pooler PM, Briand P, Leeper DB, Owen CS. Intracellular pH regulation in a nonmalignant and a derived malignant human breast cell line. J Cell Physiol 2000;18:373–89
   Google Scholar
• Hickey ED, Weber LA. Modulation of heat-shock polypeptide synthesis in HeLa cells during hyperthermia and recovery. Biochemistry 1982;21:1513–21
   PubMed Web of Science ®Google Scholar
• Han J-S, Storck CW, Wachsberger PR, Leeper DB, Berd D, Wahl ML, et al. Acute extracellular acidification increases nuclear associated protein levels in human melanoma cells during 42 °C hyperthermia and enhances cell killing. Int J Hyperthermia 2002;18:404–15
   PubMed Web of Science ®Google Scholar
• Ben-Horin H, Tassini M, Vivi A, Navon G, Kaplan O. Mechanism of action of the antineoplastic drug lonidamine: 31P and 13C nuclear magnetic resonance studies. Cancer Res 1995;55:2814–21
   PubMed Web of Science ®Google Scholar
• Vivi A, Tassini M, Ben-Horin H, Navon G, Kaplan O. Comparison of action of the anti-neoplastic drug lonidamine on drug-sensitive and drug-resistant human breast cancer cells: 31P and 13C nuclear magnetic resonance studies. Breast Cancer Res Treat 1997;43:15–25
   PubMedGoogle Scholar
• Mardor Y, Kaplan O, Sterin M, Ruiz-Cabello J, Ash E, Roth Y, et al. Noninvasive real-time monitoring of intracellular cancer cell metabolism and response to lonidamine treatment using diffusion weighted proton magnetic resonance spectroscopy. Cancer Res 2000;60:5179–86
   PubMedGoogle Scholar
• Coss RA. Inhibiting induction of heat shock proteins as a strategy to enhance cancer therapy. Int J Hyperthermia 2005;21:695–701
   PubMed Web of Science ®Google Scholar